泓博医药(301230.SZ)：AI药物设计平台已在算力、数据资源和垂直大模型方面形成系统布局

Core Viewpoint - The company has established a systematic layout in AI drug design, focusing on computing power, data resources, and vertical large models [1] Group 1 - The company possesses stable and efficient computing resources that support key tasks such as drug design, molecular simulation, and model training [1] - The company has accumulated rich data resources and built a knowledge graph, providing solid support for large models [1] - The company has independently developed a vertical large model in the biopharmaceutical field, covering functions such as literature research, drug design and evaluation, and patent infringement analysis, while continuously enhancing its intelligence capabilities [1]